OncoVista Innovative Therapies, Inc. (OTC BB: OVIT)

OncoVista Innovative Therapies, Inc. (OTC BB: OVIT), a biopharmaceutical company, is focused on developing and commercializing therapies targeted towards cancer that are designed to provide more efficiency while being less toxic. By combining their extensive in-house pre-clinical and clinical know-how with a global drug development network, the company intends to see rapid and cost-effective regulatory approval and commercialization of innovative therapies. For further information, visit the Company’s web site at www.oncovista.com.